key: cord-1041340-w7zsfb6q authors: Petters, Leanne M.; Vogel, Tiphanie P.; Munoz, Flor M.; Hernandez, Jose A.; Koohmaraie, Sarah; Nowicki, Michael J.; Zumbro, Caleb E.; Mysore, Krupa R. title: Multisystem inflammatory syndrome in children associated with SARS‐CoV‐2 in a solid organ transplant recipient date: 2021-04-02 journal: Am J Transplant DOI: 10.1111/ajt.16572 sha: 1a952938f7ea9a6c95d1a0908c246c90e8e8d7da doc_id: 1041340 cord_uid: w7zsfb6q We present the case of a 3‐year‐old female liver transplant recipient with a history of Caroli disease who presented with positive severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) reverse transcription polymerase chain reaction (RT‐PCR) test and was ultimately diagnosed with multisystem inflammatory syndrome in children (MIS‐C) complicated by portal vein thrombosis. To the best of our knowledge, this is the first case report of MIS‐C in a pediatric solid organ transplant (SOT) recipient. Based on our patient, MIS‐C could be a potential complication of Coronavirus disease 2019 (COVID‐19) in SOT recipients and may have a negative outcome on transplant graft function. Our patient is a 3-year-old African American female liver transplant recipient who presented with a positive SARS-CoV-2 reverse transcription polymerase chain reaction (RT-PCR) test and concern for MIS-C. The patient had a history of end-stage liver disease sec- She was treated with intravenous immunoglobulin (IVIG) 2 g/kg once on DOI 3. She tolerated the infusion well and subsequently had resolution of fever on DOI 4. Upon admission, the tacrolimus was held secondary to the supratherapeutic level and subsequently the dose was adjusted to maintain goal trough levels between 5 and 7 ng/ml. Enoxaparin was resumed at admission and a therapeutic level was achieved by DOI 6. Following the repeat echocardiogram, she was also started on high dose aspirin, 30 mg/kg/day for 5 days followed by 3 mg/kg/day, until a repeat echocardiogram on DOI 28, which revealed resolution of the coronary dilation. Her SARS-CoV-2 RT-PCR resulted as negative on DOI 13. the MIS-C diagnosis over Kawasaki Disease. 8 In total, her presentation was most consistent with MIS-C. Our patient did not have shock as described in the literature in two to three-quarters of MIS-C patients and did not require care in the intensive care unit. She was hemodynamically stable throughout her illness without inotropic support or decreased cardiac function F I G U R E 1 Timeline of key clinical events with associated laboratory evidence of inflammation based on day of illness Epidemiology of COVID-19 among children in China Hyperinflammatory shock in children during COVID-19 pandemic COVID-19-associated multisystem inflammatory syndrome in children -United States American college of rheumatology clinical guidance for multisystem inflammatory syndrome in children associated with SARS-CoV-2 and hyperinflammation in pediatric COVID-19: Version 1. Arthritis & rheumatology An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study The pediatric solid organ transplant experience with COVID-19: an initial multi-center, multiorgan case series Mild COVID-19 in a pediatric renal transplant recipient Multisystem inflammatory syndrome in U.S. children and adolescents Modulating immunosuppression in liver transplant patients with COVID-19 Ig-responsive relapsing inflammatory syndrome following COVID-19 in a kidney transplant recipient American Society of Transplantation. 2019-nCoV (coronavirus): FAQs for organ transplantation Coronavirus Disease 2019 (COVID-19) in autoimmune hepatitis: a lesson from immunosuppressed patients Viral upper respiratory infection at pediatric liver transplantation is associated with hepatic artery thrombosis The data that support the findings of this manuscript are available from the corresponding author upon reasonable request. https://orcid.org/0000-0002-0208-4581